Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 26, 2024 16:05 ET
|
Longeveron
Longeveron to present at HC Wainwright global investment conference.
Cell Counting Devices Market - Global Outlook & Forecast 2024-2029 by Product, Application, End-user and Region Featuring Profiles of 67 Companies Including Bio-Rad Labs, Danaher, Merck, Siemens Healthineers
August 26, 2024 09:29 ET
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Cell Counting Devices Market - Global Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Global Cell...
Induced Pluripotent Stem Cell (iPSC) Global Industry Report 2024 - Revolutionizing Medicine: The Transformative Power and Commercial Potential of Induced Pluripotent Stem Cells (iPSCs)
August 16, 2024 10:44 ET
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2024" report has been added to ResearchAndMarkets.com's...
Microcarrier Market Report 2024-2032 Featuring Manufacturing Specialists - Thermo Fisher Scientific, Eppendorf, Danaher, Sartorius, Bio-Rad Laboratories, Corning, Lonza, Getinge and BD and Co
August 16, 2024 10:33 ET
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Global Microcarrier Market Report By Applicati, End User, Countries and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's...
Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024 16:05 ET
|
Longeveron
Longeveron reports Q2 2024 financial results and provides business update. Phase 2b clinical trial in HLHS achieves 70% enrollment.
Advanced Therapy Medicinal Products Global Strategic Business Report 2023-2030: Rising Demand for Gene Therapy Spurs Market Expansion, North America and Europe Dominate
August 13, 2024 11:06 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Advanced Therapy Medicinal Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Meso Numismatics, a Renowned Leader in Regenerative Medical, Announces Global Stem Cells Groups (GSCG) Launch of Revolutionary New Line of Peptides
August 13, 2024 06:33 ET
|
Meso Numismatics, Inc.
LAS VEGAS, NV, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a renowned leader in regenerative medical company, and in the process with FINRA...
Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024
August 05, 2024 16:05 ET
|
Longeveron
Longeveron announced that it will report Q2 2024 financial results and provide a business update on Wednesday, August 14, 2024.
Exosome Diagnostics and Therapeutics Research Report 2024: Market to Grow at a Staggering CAGR of 81.2% by 2032
August 02, 2024 10:48 ET
|
Research and Markets
Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source...
NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer
August 01, 2024 16:04 ET
|
NurExone Biologic Inc
NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer